Table 3.
Parameter | DSS | LRFS | MeFS | ||||||
---|---|---|---|---|---|---|---|---|---|
H.R | 95% CI | p-Value | H.R | 95% CI | p-Value | H.R | 95% CI | p-Value | |
Tumor regression grade | 2.262 | 1.1198–4.566 | 0.023 * | 2.198 | 1.002–4.831 | 0.015 * | 2.32 | 1.063–4.292 | 0.033 * |
CHD4 expression | 1.181 | 0.519–2.686 | 0.692 | - | - | - | 4.575 | 1.717–12.192 | 0.002* |
Vascular invasion | 2.082 | 0.771–5.622 | 0.148 | 2.510 | 0.902–6.985 | 0.078 | - | - | - |
Post-Tx tumor status (Post-T) | 2.447 | 0.992–6.034 | 0.052 | 2.041 | 0.825–5.051 | 0.123 | 1.736 | 0.751–4.012 | 0.197 |
Pre-Tx nodal status (Pre-N) | 1.286 | 0.538–3.070 | 0.571 | 1.993 | 0.833–4.770 | 0.121 | - | - | - |
Pre-Tx tumor status (Pre-T) | 1.283 | 0.532–3.096 | 0.579 | - | - | - | - | - | - |
Perineural invasion | - | - | - | 1.122 | 0.231–5.447 | 0.887 | - | - | - |
H.R., hazard ratio *, statistically significant.